February 4, 2020
Avisa Pharma Inc. (“AVISA” or “the Company”), a medical device company developing a drug/device biomarker technology platform[...]
September 18, 2018
Ten-minute, point-of-care breath test rapidly detects virulent bacterial infections to mitigate overuse of antibiotics and save[...]

Subscribe to receive our press releases

Stock Info:
CSE:   AVBT $0.00